Company Overview - Corteva, Inc. (CTVA) has a market capitalization of $52.7 billion and operates in the agriculture sector, providing services across various global markets including North America, Latin America, Asia Pacific, Europe, the Middle East, and Africa [1] - The company has two main segments: Seed and Crop Protection, focusing on advanced seed genetics, traits, and crop protection products to enhance farm productivity and resilience [1][2] Stock Performance - Corteva's shares have decreased by 3.9% from their 52-week high of $80.90, but have increased by 18.6% over the past three months, outperforming the Nasdaq Composite, which declined by 4% during the same period [3] - Year-to-date, CTVA stock is up 15.1%, while the Nasdaq Composite has dropped by 2.3%. Over the past 52 weeks, the stock has returned 28.1%, lagging behind the Nasdaq's 30% return [6] Financial Results - Following the Q4 2025 results, Corteva's shares rose slightly as the adjusted EPS of $0.22 met Wall Street expectations. The company reported a full-year income of $1.20 billion ($1.75 per share) on sales of $17.40 billion, with operating cash flow increasing by 51% to $3.5 billion and free cash flow rising by 69% to $2.9 billion [7] - Management has provided a 2026 outlook of $4 billion to $4.2 billion in operating EBITDA and $3.45 to $3.70 in operating EPS, despite quarterly revenue of $3.91 billion falling short of consensus estimates [8] Analyst Sentiment - Analysts maintain a moderately optimistic outlook for CTVA stock, with a consensus rating of "Moderate Buy" from 22 analysts. The mean price target is set at $83.35, indicating a potential upside of 7.3% from current levels [9]